Study identifies causes of bone loss in breast cancer survivors
... calcium excretion in urine and an overactive parathyroid gland. "Doctors evaluating breast cancer ... patients. And in 5 percent of patients, the parathyroid gland was overactive, producing a hormone that ... Camacho said. There are various treatments for parathyroid gland disorder, depending on its cause. In ...Too much calcium in blood may increase risk of fatal prostate cancer
... strongly associated with it, such as high serum parathyroid hormone, increases the risk for fatal prostate ... that reduce serum levels of calcium and/or parathyroid hormone." He added, "Both calcium and parathyroid hormone are known to promote the growth of ...Low Vitamin D Tied to Depression in Older Adults
... Poor levels also cause increase in serum parathyroid hormone readings, study says FRIDAY, ... D and high levels of a hormone secreted by the parathyroid glands may increase the risk of depression in ... poor vitamin D status causes an increase in serum parathyroid hormone levels. Symptoms of depression often ...Vitamin D Use Linked to Lower Mortality in Kidney Patients
... often take calcitriol to treat elevated levels of parathyroid hormone (hyperparathyroidism), a condition that ... clinical knowledge is limited to its effect on parathyroid hormone levels," study co-author Dr. Bryan ... appeared to be unrelated to its effect on parathyroid hormone levels. The study is published in the ...The Second National Audit Report of the BAETS
... thyroid surgery was only 79%. The analysis for parathyroid surgery includes data from 1,896 procedures ... than ten cases each year. Like thyroid surgery, parathyroid surgery is consultant-led with evidence of ... collection. Overall, there were good outcomes for parathyroid disease and the evidence clearly shows good ...New protein discovery helps researchers understand autoimmune diseases
... the target for the immune systems attacks on the parathyroid glands in the disease APS-1. This finding enables ... University, who made the discovery. The parathyroid glands are the most recently described anatomical ... The fact that the protein NALP5 was found in the parathyroid glands enhances our understanding of their ...JCI table of contents: Nov. 8, 2007
... NEPHROLOGY: A bone to pick with the parathyroid A careful balance of mineral levels in the ... have demonstrated a link between FGF23 and the parathyroid gland, an organ that is vital in calcium homeostasis. The parathyroid glands ...PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
... most often caused by injury to or removal of the parathyroid glands during neck surgery. It also occurs as an ... palliative therapies, the absence of endogenous parathyroid hormone compromises the body's ability ... . About PREOS PREOS is recombinant human parathyroid hormone (PTH). NPS has studied PREOS in a number ...Dilon Technologies' Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
... Uses include: breast imaging; sentinel node imaging; thyroid imaging; and parathyroid imaging. LEHR collimator is a high-resolution collimator for general nuclear medicine applications. Uses include thyroid imaging, parathyroid imaging, sentinel node imaging, spot bone imaging, gall bladder ejection, ...VAI Finding Could Lead to New Drugs for Anxiety, Depression
... to form salt crystals but much more difficult. The lab used a unique method to do this that they recently developed to determine the structure of the parathyroid hormone (PTH) receptor, used to treat osteoporosis. PTH and CRF receptors are in the same family of proteins. "There are many therapeutically ...Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
... -- Satiety and oral glucose challenge studies for both GLP-1 and PYY will be undertaken later this year at University Hospital, Switzerland -- parathyroid hormone continues on a progressive clinical development path in collaboration with Novartis Pharma AG Emisphere has 11 products in preclinical ...Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
... the United States -- A food-intake study for both GLP-1 and PYY will be undertaken later this year at University Hospital, Switzerland -- parathyroid hormone continues on a progressive clinical development path in collaboration with Novaris Pharma AG Emisphere has 11 products in preclinical ...Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
... and charged organics. Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and cromolyn sodium into clinical trials. Emisphere has strategic alliances with world-leading pharmaceutical ....Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
... calcium, serum ionized calcium and serum phosphorus. No drug-related adverse events were reported. Significant reduction in the blood levels of parathyroid hormone (PTH) was observed in this trial, suggesting that CTA018 has potential as a treatment for secondary hyperparathyroidism in chronic kidney ...Intact PTH EIA Bone and Mineral Metabolism 021-SDX016 Parathyroid Hormone
Description:... Intact PTH EIA Bone and Mineral Metabolism 021-SDX016 parathyroid ...U-M scientist to talk about tissue engineering at AAAS
... therapies to improve the benefits of tissue engineering. For example, parathyroid hormone is given to patients with osteoporosis, a condition in which bone quality declines leaving them fragile and prone to breaking. parathyroid hormone stimulates bone growth in these patients, and Krebsbach sees ...NPS Pharmaceuticals Announces Approval of Cinacalcet HCl in Japan
... on dialysis. It regulates the over-secretion of parathyroid hormone (PTH) in patients with chronic kidney insufficiency by acting directly on the parathyroid gland calcium-sensing receptor. Elevated levels ... of elevated levels of calcium in patients with parathyroid carcinoma. NPS president and CEO Dr. Tony Coles ...PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
... most often caused by injury to or removal of the parathyroid glands during neck surgery. It also occurs as an ... palliative therapies, the absence of endogenous parathyroid hormone compromises the body's ability ... . About PREOS PREOS is recombinant human parathyroid hormone (PTH). NPS has studied PREOS in a number ...Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
... to advance the company's novel therapeutic programs, including its lead product Zosano PTH Patch, a proprietary transdermal patch formulation of parathyroid hormone (PTH) for the treatment of established osteoporosis. "Gail brings a tremendous track record of executive leadership to Zosano, and her ...Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World
... index score of less than or equal to 5, according to Black et al(v). Bone medications included bishosphonates, raloxifene, strontium ranelate, parathyroid hormone (1-84), teriparatide, tibolone, and calcitonin. GLOW is being conducted by The Center for Outcomes Research (COR), University of ...Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
... glucose challenge studies for both GLP-1 and PYY were started in humans with data expected during the second quarter of this year; and -- parathyroid hormone and human growth hormone are in development in collaboration with Novartis Pharma AG Emisphere conducts a variety of preclinical ...Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results
... oral glucose challenge studies for both GLP-1 and PYY were started in humans with data expected during the second quarter of this year -- parathyroid Hormone and Recombinant Human Growth Hormone continue on a development path in collaboration with Novartis Pharma AG Emisphere conducts a ...Stonegate Report About Unigene Laboratories Inc.
... of peptides and patented technologies for the oral and nasal delivery of peptides. The Company has also licensed the worldwide rights to its oral parathyroid (PTH) technology to GlaxoSmithKline (NYSE: GSK ) and the worldwide rights for its calcitonin manufacturing technology to Novartis Pharma AG (NYSE: ...NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
... two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 ...NPS Pharmaceuticals Announces Senior Management Changes
... two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism (parathyroid hormone 1-84 [rDNA ...Rabbit Anti-Human Parathyroid Hormone Receptor 2 Polyclonal Antibody, Unconjugated from Abcam
Description:... Rabbit polyclonal to parathyroid Hormone Receptor 2 ( Abpromise for all tested applications). Antigen: ... corresponding to extracellular amino acids 99-116 of Human parathyroid Hormone Receptor 2 Entrez Gene ID: 5746 Swiss Protein ID: ...